-The 103rd Congress of the Japan Gastroenterological Endoscopy Society-
Call for Abstracts
- 1. Abstracts in English
- 2. Submission Period
- 3. Requirements
- 4. Presentation & Category Type
- 5. Instruction for Preparing Abstract
- 6. Notification of Receiving Abstract
- 7. Notification of Acceptance of Abstract
- 9. Abstract Submission
- 10. Contact Information
1. Abstracts in English
Submissions for core sessions and general presentations must be submitted online from the JGES website.
Please click "New submission" at the bottom of this page.
2. Submission Period
Open: 12:00pm Wednesday, September 22, 2021 (JST)
Close: 6:00pm Friday, November 12, 2021 (JST)→ 6:00pm Friday, November 26, 2021 (JST)
*We will extend the period of the call for abstracts for 103JGES. There will be no further extensions after that.
*The designated speakers requested by the Acting Secretariat of the 103JGES will be contacted separately.
● Please carefully read the following notifications before your abstract submission.
1. The abstract should be unpublished at the Annual Meeting of the Japan Gastroenterological Endoscopy Society (JGES) and the other scientific meetings.
Notice: The accepted abstracts for the international sessions will be published in Digestive Endoscopy.
2. No conflict with ethical regulations
Medical research involving human subjects, including research on samples and data of human origin, should be approved by the Ethics Committee, and informed consent should be obtained in accordance with the Declaration of Helsinki. If an ethical issue is suspected by the Editorial Board, it will be discussed by the Ethics Committee of the Society. To protect the privacy of individuals, please refrain from using expressions that may identify individuals in the images and other materials presented.
3. Conflict of Interest
Before you submit the abstract, please be sure to read through “Conflict of Interest” page.
4. The conference proceedings will be available through an app for smartphones and tablets. Please understand that the accepted abstracts will be electronically published.
5. You cannot apply for more than one doctor from the same organization to submit the same subject as the first author. In this case, please note that both abstracts will be withdrawn. However, if the first author belongs to a different organization, they can apply as a co-presenter. If you are submitting an abstract for a multi-institutional study, please use the name of the organization, or use a title that identifies the study as a multi-institutional study.
6. You cannot submit the same contents in different categories. Abstracts considered to be the same will be discussed by the reviewers and program committee. Please note that when the abstracts are judged to be identical, both will be rejected. For categories, please see 4. Categories and Presentation type.
7. Withdrawal and absence
Please be aware that any author that withdraws an abstract after acceptance notification or is absent without notice on the day of presentation may possibly be penalized according to the rules of JGES.
4. Presentation & Category Type
●Presentation type *Please choose one.
01. Apply for theme sessions: Withdraw the abstract if not accepted
02. Apply for theme sessions: Oral Presentation if not accepted
03. Apply for theme sessions: Poster Presentation if not accepted
04. Apply for theme sessions: Oral or Poster（Either Presentation）if not accepted
05. Oral Presentation preferred
06. Poster Presentation preferred
07. Oral or Poster （Either Presentation）
*If you choose "01. Abstract submission: Withdraw the abstract if not accepted", up to two co-authors can be registered.
*If you select "02. to 04. Apply for theme sessions: if not accepted": please be sure to select numbers 1 and 2 in the "Presenter’s order" column for the co-authors to be listed in the abstract book if your abstract is accepted. Please note if you do not select the order of presenters, co-authors 1 and 2 will be listed.
English on abstract, presentation slides, presentation and discussion
After your presentation is accepted, please be sure to complete registration, including paying the registration fee. If you come to the venue physically, please come to the PC data reception desk on site. If you are unable to attend physically, you may give your presentation on the web. In that case, please be sure to complete your registration without fail. Otherwise, your achievement may not be approved.
●Theme Sessions Call for Abstract
★JGES International (English Session)
Upper GI 8 International Workshop
Diagnosis and Treatment Strategies for Barrett's esophageal adenocarcinoma -cutting edge from all over the world
Tsuneo Oyama, Gastroenterology, Saku Central Hospital Advanced Care Center
Toshiro Iizuka, Department of Gastrointestinal Endoscopy, Tokyo Metropolitan Cancer and Infectious Diseases Komagome Hospital
David Carr-Locke, NewYork-Presbyterian/Weill Cornell Medical Center
Barrett's esophagus cancer is slowly increasing in Japan, and early diagnosis is essential. From the viewpoint of safety and curability, minimally invasive treatment methods followed by additional treatments should be considered based on histological examination.
In the process from diagnosis to treatment, there are many aspects that are still unclear. In this workshop, we would like to discuss the novel diagnosis methods and cutting-edge treatment strategies for Barrett esophageal adenocarcinoma, for example, how to diagnose early cancer of LSBE, how to handle non-cancerous areas of LSBE, how to treat whole superficial circumferential lesions of EGJ, risk factors for lymph node metastasis, or how to treat lesions with inflammation, etc. Abstracts with high originality are welcome, even if they are based on a small number of cases.
★JGES International (English Session)
Lower GI 11 International Symposium
Optimizing the monitoring strategy of Crohn’s disease
Masayuki Saruta, Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine
Taku Kobayashi, Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital
Nalini M. Guda (Aurora Health Care, Wisconsin, U.S.A）
Crohn’s disease (CD) is a form of inflammatory bowel diseases that may affect any parts of the digestive system, from the mouth to the anus. Recent advances in medical treatments have lead to the emergence of a concept of treat-to-target to achieve better long-term outcomes by tightly controlling the disease activity and avoiding bowel damage which may result in the need for surgery. However, there is no “gold standard” on the monitoring strategy of disease activity. Recently, there have been breakgthroughs also in the diagnostic tools of the gastrointestinal tract. Small bowel follow-through and computed tomography have been conventionally used in combination with the upper/lower gastrointestinal endoscopy. Capsule endoscopy, balloon-assisted enteroscopy, and magnetic resonance enterography are now widely available in most tertiary referral centers while they are not suitable for frequent monitoring because of their invasiveness and/or accessibility. Therefore, bowel ultrasound and biomarkers (fecal calprotectin and leucine-rich glycoprotein) have drawn attention as non-invasive monitoring tools of CD in the last decade. In this symposium, optimal monitoring strategy will be discussed to pursue a treat-to-target approach and improve the outcomes of CD.
★JGES International (English Session)
Bile duct and Pancreas 4 International Symposium
New development of endoscopic ultrasound in digestive disease
Atsushi Irisawa, Department of Gastroenterology, Dokkyo Medical University School of Medicine
Hijioka Susumu, Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital
Luis Sabbagh, Reina Sofía Clinic & Colombia University Clinic, Bogota, Colombia
Endoscopic ultrasound (EUS) has become widely used as a diagnostic and therapeutic modality for treating pancreatobiliary diseases. Moreover, EUS have made great advancement in the diagnosis and treatment of pancreatobiliary diseases. It has only been 30 years since EUS was first applied clinically. However, there has been a remarkable evolution in diagnostic imaging criteria using EUS, including the development of diagnostic methods using new techniques and devices such as contrast-enhanced EUS and EUS elastography, development of tissue diagnosis or tissue acquisition for cancer gene panel test using EUS-FNA, and development of new therapeutic methods such as drug infusion and drainage. Since this session is a symposium, we wish to request that you make a comprehensive presentation on the new developments in EUS for biliopancreatic diseases in general, evaluate the current status of EUS, and clarify new insights and prospects for developments in the next-generation EUS. We look forward to receiving a wide range of submissions.
●Categories and Presentation type
○Content Category 1 *Please choose one.
|01||Oral and oropharyngeal||06||Large intestine|
|2||Functional disease||19||Varicosis treatment|
|3||Infectious disease（Including H. pylori）||20||Ultrathin endoscopes (including perinasal endoscopy)|
|4||Inflammatory disease||21||Ultrathin endoscopes (including perinasal endoscopy)|
|5||Image management systems||22||Capsule endoscopy|
|6||Image analysis and processing||23||Intestinal endoscopy|
|7||Endoscope cleaning and disinfection||24||Gastrostomy|
|8||Pretreatment and perioperative management||25||Stents and dilation|
|9||Sedation||26||Laser treatment and PDT|
|10||Education and training||27||Diagnostic laparoscopy|
|11||Risk management (including elderly patients)||28||Laparoscopic surgery|
|12||Magnification, high-magnification, and image-enhancing endoscopy||29||Foreign body removal|
|13||ESD and EMR||30||Obesity treatment|
|14||New minimally invasive endoscopy||31||Notes|
|16||EUS and FNA technique||33||Other|
|17||ERCP and ERCP-related technique|
The poster presentation format will be announced in late December.
5. Instruction for Preparing Abstract
Abstracts should be prepared in the following manners:
1. Refer to the glossary of JGES and use appropriate terminology.
If you are a member of JGES, the 4th edition of the Glossary of Gastrointestinal Endoscopy is available. Member’s number and password are required to review.
2. Title of presentation: Maximum of 60 double-byte characters
3. Maximum number of authors (first author + co-authors): 21 or less
Please note that if your presentation is accepted as Theme Sessions, up to two co-authors will be listed on the online abstract. For details on how to register, please refer to the registration page.
4. Maximum number of affiliated institutions: Up to 10 institutions
5. Abstract body: There should be within 2170 one-byte characters including title, authors' names and affiliations and spaces. (In case of using pictures and/or graphs, the abstract body should be within 1410 one-byte characters including title, authors' names and affiliations and spaces.)*Please refer to the registration page for further detail.
6. Notification of Receiving Abstract
After submitting your abstract, you will receive a completion e-mail, which will serve as a notification of the receipt of your abstract submission. For security reasons, we will not respond to any inquiries about your password after registration. If you lose your password, you will be required to register again. The abstract with the lost password will be discarded. If you wish to delete an abstract for which you have lost your password, please contact the secretariat by e-mail (firstname.lastname@example.org).
7. Notification of Acceptance of Abstract
You will be notified of the acceptance or rejection of your abstract at the e-mail address you entered when you submitted your abstract. Please be sure to enter a valid e-mail address that you check regularly, as we will send you important information by e-mail.
The 103JGES entrusts the personal information, such as name, contact information, and e-mail address, collected at the abstract submission for this conference will be used for inquiries from the secretariat and notification of presentations. Names, affiliations, abstract titles, and the text of abstracts will be used only for the purpose of publishing them on the website and in the abstract collection and will not be used for any purposes other than stated above. After the conference, we will ensure that information is protected from outside parties.
9. Abstract Submission
This system has been tested with the latest versions of Internet Explorer, Google Chrome, Mozilla Firefox, and Safari. Please do not use other browsers.
*Before you submit the abstract, please read the instruction to understand the purpose of the session.
10. Contact Information
Acting Secretariat of the 103JGES
c/o Convention Academia, Inc.
#4F Hongo-UC Building, 3-35-3 Hongo,
Bunkyo-ku, Tokyo 113-0033 JAPAN